Overactive Bladder Clinical Trial
Official title:
Acupuncture on Post-Stroke Overactive Bladder: A Randomized Controlled Trial
NCT number | NCT02568774 |
Other study ID # | AcupPSOAB |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | August 2015 |
Est. completion date | August 2018 |
Verified date | October 2018 |
Source | The University of Hong Kong |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study evaluates the effect of acupuncture on post-stroke overactive bladder symptoms. Participants will be put into groups randomly and compared. There are two groups: traditional acupuncture and usual care. The ratio of group allocation is 1:1.
Status | Completed |
Enrollment | 34 |
Est. completion date | August 2018 |
Est. primary completion date | August 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Chinese aged 18 or above 2. Patient suffering from first ever stroke or recurrent stroke with no urinary symptom in previous episode(s); 3. Patient with classic symptoms, i.e. urgency, urinary frequency or urge incontinence and Overactive Bladder Symptom Score (OABSS) score =3 and the urgency item rated as at least 2-point; 4. Not taking any medication for OAB 5. Able to communicate 6. No current acupuncture or transcutaneous electrical nerve stimulation treatment Exclusion Criteria: 1. Urinary retention with post-void urinary volume > 100ml; 2. Current urinary tract infection; 3. Preexisting history of OAB or bladder outlet obstruction or underactive bladder; 4. Significant cognitive impairment with MMSE < or =19; 5. Coexisting Alzheimer's disease, Parkinson's disease, spinal cord disorder or progressive neurological disease such as multiple sclerosis; 6. Active skin lesion or open wound over the needle placement areas; 7. Having valvular heart defects, severe cardiac diseases, or bleeding disorders, 8. Being fitted with any implanted electrical device such as pacemaker, defibrillator, or brain stimulation; 9. Pregnant; 10. Malignancies at the sites of selected acupoints; 11. Receiving acupuncture treatment 1 month before baseline. |
Country | Name | City | State |
---|---|---|---|
China | Shanghai TCM-INTEGRATED Hospital, Shanghai University of Traditional Chinese Medicine | Shanghai | |
Hong Kong | Tung Wah Eastern Hospital | Hong Kong | |
Hong Kong | Tung Wah Hospital | Hong Kong |
Lead Sponsor | Collaborator |
---|---|
The University of Hong Kong |
China, Hong Kong,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | AE measured by open-ended questions | open-ended questions about the experience of adverse events | first week of treatment, second week of treatment, third week of treatment, 1-week posttreatment, 4-week posttreatment | |
Primary | Overactive Bladder Symptom Scale (OABSS) | four item questionnaire quantifies overactive bladder symptoms in a single score | 1-week posttreatment | |
Secondary | Number of incontinent episodes measured by bladder diary | Record the frequency of day and night time voiding and incontinence episodes over 3 day periods | 1-week posttreatment, 4-week posttreatment | |
Secondary | Stroke Specific Quality of Life Scale (SS-QoLS) | 12 items questionnaire consists of physical and psychosocial subscales: amount of help required completing a task, trouble experienced performing a task and functioning. | 1-week posttreatment, 4-week posttreatment | |
Secondary | Medication measured by bladder diary | number of patients requested medication for OAB from bladder diary. | 1-week posttreatment, 4-week posttreatment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04578899 -
"The Effectiveness of Transvertebral Magnetic Neuromodulation in Patients With Detrusor Overactivity"
|
N/A | |
Active, not recruiting |
NCT03556891 -
Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary Incontinence
|
N/A | |
Not yet recruiting |
NCT05977634 -
Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder
|
N/A | |
Completed |
NCT01955408 -
Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment
|
N/A | |
Recruiting |
NCT06201013 -
Efficacy and Safety of Vitamin D in the Treatment of OAB-wet in Children
|
N/A | |
Recruiting |
NCT03727711 -
TPTNS: Home vs Hospital Treatment for Overactive Bladder
|
N/A | |
Completed |
NCT00768521 -
A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107)
|
Phase 1 | |
Completed |
NCT03625843 -
Mindfulness Exercises to Reduce Anxiety and Pain During Urodynamic Testing
|
N/A | |
Completed |
NCT02211846 -
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorption System) in Pediatric Subjects With Neurogenic Detrusor Overactivity or Overactive Bladder
|
Phase 1 | |
Completed |
NCT02857816 -
PRospective Study to Evaluate EffectivenesS With the NURO™ PErcutaneous Tibial Neuromodulation System in Patients With OAB
|
N/A | |
Completed |
NCT02835846 -
Investigation of the Effect of the Female Urinary Microbiome on Incontinence
|
Phase 4 | |
Completed |
NCT02202031 -
Controlling Urgency Through Relaxation Exercises
|
N/A | |
Withdrawn |
NCT02320201 -
Foot Neuromodulation for Overactive Bladder in Children
|
N/A | |
Not yet recruiting |
NCT01423838 -
Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder
|
Phase 4 | |
Completed |
NCT01458197 -
A Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo in Patients Suffering From Overactive Bladder.
|
Phase 2 | |
Not yet recruiting |
NCT01409512 -
Evaluation of Autonomic System Before and After Anticholinergic Treatment in Women With Overactive Bladder
|
N/A | |
Completed |
NCT01437670 -
Observational Study to Estimate the Dry Mouth in OAB Patients With Solifenacin
|
N/A | |
Terminated |
NCT01758848 -
Physical Therapy for Overactive Bladder
|
N/A | |
Withdrawn |
NCT01210859 -
Effects of Antimuscarinic Drugs on Overactive Bladder (OAB) Symptoms After Insertion of Ureteral Stents
|
N/A | |
Completed |
NCT01122563 -
A Study to Evaluate Response of Overactive Bladder Symptom Score (OABSS) to Treatment
|
N/A |